Synapse 3D Liver and Kidney Analysis
by Fujifilm Meidcal Systems U.S.A., Inc.
510(k) K142521
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK142521 | Date1 Dec 2014 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- LLZ
- FDA applicant
- Fujifilm Meidcal Systems U.S.A.,Inc.
- Device Class
- Class II
- Regulation
- 21 CFR Part 892.2050
- Advisory Committee
- Radiology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 19 Sep 2026
Synapse 3D Liver and Kidney Analysis is a medical imaging software tool designed for three-dimensional analysis of liver and kidney structures. It processes contrast-enhanced CT and MR images to generate segmented 3D visualisations, enabling detailed anatomical assessment and preoperative planning, including liver segmentation and hepatectomy simulation.
The software is supplied as part of the Synapse 3D Base Tools platform and is intended for use by trained medical imaging professionals, such as radiologists and physicians. It operates on contrast-enhanced imaging data, producing 3D masks for surgical planning and embolization procedures. The device holds FDA 510(k) clearance under the product code LLZ, with a traditional review pathway through the Radiology Advisory Committee.